In particular, the charges have targeted two lawmakers typically seen as pharma foes: Sens. Bernie Sanders (I-Vt.) and ...
NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities ...
If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.
AstraZeneca placed Wang on extended leave ... Defensecategory Market conditions not ideal for Aeromexico IPO in New York, CEO says 6:10 PM UTC · Updated ago Legalcategory Thomson Reuters wins ...
The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool ... in ...
The firms will evaluate two adjuvant treatment options, Datroway with rilvegostomig or rilvegostomig monotherapy, against standard-of-care treatment.
The Associated Press - Business News on MSN13d
AstraZeneca scraps plan to expand vaccine plant in the UK in blow to governmentPharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.
Recent health news includes Pfizer settling a lawsuit about a diversity fellowship, a New York doctor indicted for prescribing abortion pills in Louisiana, AstraZeneca canceling UK investment, ...
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback